Capravirine Clinical Trials Restricted
Drug restricted in patients until additional safety evaluation resolved
30-Jan-2001 -
Pfizer announced today that it has restricted use of its investigational drug capravirine for some patients in clinical trials based on results of a 12-month animal
toxicology study, which demonstrated an unexpected finding of vasculitis. This decision was reached in discussions with the FDA ...
AIDS
clinical trials
diseases
+6